Recent study has documented that Nrf2 was overexpressed in osteosarcoma tissues, and the 5-year survival rate was remarkably higher in patients with negative Nrf2 expression than in those with positive expression27. The gene discussed is NFE2L2; the disease is osteosarcoma.